Neogen Co. (NASDAQ:NEOG – Get Free Report) CEO John Edward Adent acquired 23,000 shares of the business’s stock in a transaction dated Wednesday, April 10th. The stock was acquired at an average price of $12.36 per share, with a total value of $284,280.00. Following the completion of the transaction, the chief executive officer now directly owns 152,389 shares of the company’s stock, valued at $1,883,528.04. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Neogen Price Performance
NEOG opened at $13.00 on Friday. The stock’s 50-day moving average price is $15.88 and its 200 day moving average price is $16.77. Neogen Co. has a 12-month low of $12.18 and a 12-month high of $24.09. The company has a current ratio of 3.54, a quick ratio of 2.63 and a debt-to-equity ratio of 0.28. The firm has a market cap of $2.81 billion, a price-to-earnings ratio of 216.70 and a beta of 1.13.
Neogen (NASDAQ:NEOG – Get Free Report) last posted its earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). Neogen had a return on equity of 3.35% and a net margin of 1.28%. The firm had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. During the same period in the previous year, the company posted $0.12 EPS. Neogen’s revenue was up 4.8% on a year-over-year basis. As a group, sell-side analysts expect that Neogen Co. will post 0.54 earnings per share for the current year.
Hedge Funds Weigh In On Neogen
Analyst Upgrades and Downgrades
Separately, Piper Sandler boosted their price objective on Neogen from $17.50 to $19.00 and gave the stock a “neutral” rating in a research note on Thursday, January 18th.
Check Out Our Latest Stock Analysis on Neogen
About Neogen
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Featured Stories
- Five stocks we like better than Neogen
- Canada Bond Market Holiday: How to Invest and Trade
- Here are the Pros and Cons of Using Options Call Debit Spreads
- Technology Stocks Explained: Here’s What to Know About Tech
- Carmax Returns to the Bargain Basement: Buy the Dip?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.